Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3658_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •2 Principles of radiofrequency and microwave tumor ablation
- •Cooling in microwave ablation
- •Pulsed RF application
- •Operator and technique
- •Choice of applicator
- •Overlapping techniques
- •Introduction
- •Biology of heating
- •Radiofrequency ablation
- •Microwave ablation
- •Energy-deposited technology
- •Multitine applicators
- •Internally cooled electrodes
- •Perfused electrodes
- •Ancillary procedures
- •Combination therapies
- •Combining RF with transarterial chemoembolization
- •Combining RF with chemotherapy
- •Combining RF ablation with radiation
- •Patient selection
- •Conclusion
- •References
- •3 Principles of irreversible electroporation
- •Introduction
- •Numerical simulations
- •Clinical considerations
- •Clinical experience
- •Conclusion
- •References
- •4 Principles of high-intensity focused ultrasound
- •Introduction
- •History
- •Ablation
- •Hyperthermia
- •Thermal dose concept
- •Cavitation
- •Histotripsy
- •Microstreaming
- •HIFU system technology
- •Ultrasound guidance
- •MRI guidance
- •HIFU devices
- •Clinical applications
- •Prostate
- •Breast
- •Liver
- •Bone
- •Emerging applications
- •Targeted drug delivery
- •Blood–brain barrier disruption
- •Conclusion
- •References
- •5 Principles of tumor embolotherapy and chemoembolization
- •Tumor embolotherapy
- •General indications
- •Embolic materials
- •Gelfoam
- •Coils
- •Absolute ethanol
- •Microspheres
- •Pre-embolization evaluation
- •Roadmap and superselective arteriography
- •Chemoembolization
- •Basic principle
- •Chemotherapeutic agents used for chemoembolization
- •Lipiodol chemoembolization
- •Subsegmental chemoembolization
- •Drug-eluting bead TACE (DEB-TACE)
- •References
- •6 Principles of radioembolization
- •Introduction
- •Mechanism of radioembolization
- •Radioembolic material
- •Indications and contraindications
- •Imaging considerations
- •Base and follow-up cross-sectional imaging
- •Localization imaging (nuclear medicine imaging)
- •Determining treatment dosage (activity)
- •(Y-90) SIR-Sphere
- •(Y-90) TheraSphere
- •Microcatheters
- •(Y-90) SIR-Sphere
- •(Y-90) TheraSphere
- •Radiation safety considerations
- •Patient release
- •Radiation safety considerations for cases involving surgery
- •Radiation safety considerations in case of autopsy, burial, or cremation
- •References
- •Background
- •Regional delivery of the drug leads to increased local concentration
- •Increased local concentration leads to increased therapeutic response
- •Regional delivery of a drug leads to decreased systemic exposure
- •5-Fluorouracil
- •Irinotecan
- •Oxaliplatin
- •Hepatic artery combination chemotherapy administration
- •Hepatic intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI)
- •Therapeutic monoclonal antibodies
- •Future research
- •Regional therapy pharmacology appendix
- •Pharmacology appendix
- •References
- •Introduction
- •Imaging for procedure planning
- •Imaging for device delivery
- •Advances in real-time imaging
- •Three-dimensionality
- •Navigation
- •Robotics
- •Combining best systemic chemotherapy with best HAI strategy
- •Open access to the patient
- •Radiation exposure
- •Intraprocedural monitoring
- •Imaging for therapy assessment
- •Summary
- •References
- •9 Novel developments in MR assessment of treatment response after locoregional therapy
- •Anatomic biomarkers
- •The volumetric approach
- •Conclusion
- •References
- •10 Assessment and triage of hepatocellular carcinoma
- •Summary
- •Introduction
- •Assessment of hepatocellular carcinoma
- •Diagnostic criteria
- •Clinical staging
- •Triage of hepatocellular carcinoma
- •Liver transplantation
- •Surgical resection
- •Image-guided ablation
- •Transarterial treatment
- •Systemic treatment
- •Conclusion
- •References
- •11 Image-guided ablation of hepatocellular carcinoma
- •Introduction
- •Very-early-stage hepatocellular carcinoma
- •Early-stage hepatocellular carcinoma
- •Conclusion
- •References
- •Celiac trunk anatomy
- •Normal celiac trunk anatomy and variations
- •Celiac stenosis or occlusion
- •Hepatic artery anatomy
- •Intrahepatic variations in branching segmental hepatic arteries
- •Non-hepatic arteries arising from hepatic arteries
- •Pancreaticoduodenal arteries
- •Extrahepatic collateral arteries
- •Anatomy of extrahepatic collateral arteries
- •Inferior phrenic arteries
- •Internal mammary arteries
- •Intercostal and lumbar arteries
- •Omental arteries
- •Adrenal arteries
- •Renal and renal capsular arteries
- •Gastric arteries
- •Colic branches
- •Transcatheter management of extrahepatic collateral arteries
- •References
- •Background
- •Patient selection and contraindications for TACE and DEB-TACE
- •Technique
- •Follow-up and evaluation of response to treatment
- •Clinical outcome
- •Combination therapies
- •Conclusion and outlook
- •References
- •Patient selection
- •Technique
- •Dosimetry
- •Adverse events and toxicities
- •Clinical outcomes
- •References
- •15 Image-guided therapy of intrahepatic cholangiocarcinoma
- •Curative therapies
- •Percutaneous ablation
- •Non-curative therapies
- •Chemoembolization
- •Radioembolization
- •Multidisciplinary approach
- •References
- •Introduction
- •Indications
- •Contraindications
- •Ablation modalities
- •Radiofrequency ablation
- •Cryoablation
- •Microwave ablation
- •Irreversible electroporation
- •Laser-induced interstitial thermotherapy
- •Discussion
- •References
- •17 Assessment, triage, and chemoembolization for colorectal liver metastases
- •Assessment of the patient with liver metastases
- •Triage of patients with liver metastases
- •Resection
- •Ablation
- •Intra-arterial chemoinfusion
- •Systemic therapy
- •Chemoembolization
- •Patient selection for chemoembolization
- •Chemoembolization regimens
- •“Conventional” cocktails
- •Drug-eluting microsphere platforms
- •Technical aspects of chemoembolization
- •Loading
- •Technique for drug-eluting microsphere embolization
- •Delivery endpoints
- •Outcomes with drug-eluting microspheres
- •Summary
- •References
- •18 Radioembolization for colorectal liver metastases
- •Introduction
- •Patient presentation
- •Preimplantation workup procedure
- •Treatment process
- •Dosimetry and dose calculation
- •TheraSphere
- •SIR-Spheres
- •Postprocedural care and follow-up
- •Postprocedure considerations
- •Postembolization syndrome (20–30%)
- •CT/PET evaluation of tumor response
- •Radioembolization combined with second- or third-line chemotherapy
- •Conclusion
- •References
- •19 Assessment, triage, and liver-directed therapies for neuroendocrine tumor metastases
- •Terminology
- •Demographics and epidemiology
- •Diagnosis
- •Prognosis
- •Multidisciplinary triage of neuroendocrine neoplasms
- •Systemic therapies
- •Surgical management
- •Image-guided therapy
- •Tumor ablation
- •Hepatic arterial therapy
- •Conclusion
- •References
- •20 Preoperative portal vein embolization
- •Mechanisms of liver regeneration
- •Rate of liver regeneration
- •Standard approaches
- •Additional approaches
- •PVE in conjunction with transarterial therapies
- •Extent of embolization
- •Embolic materials
- •Complications
- •General indications
- •General contraindications
- •Underlying liver disease
- •High-dose chemotherapy
- •Conclusion
- •References
- •Photodynamic therapy
- •Radiotherapy
- •References
- •Clinical overview
- •Staging
- •Diagnosis
- •Treatment options
- •Surgery
- •Percutaneous techniques
- •Radiofrequency ablation
- •Background
- •Histology of RFA
- •Microwave ablation
- •Background
- •Histology
- •Cryoablation
- •Background
- •Histology of cryoablation
- •Indications for percutaneous ablation
- •Patient factors
- •Preablation imaging
- •Adjunctive procedures
- •Technique
- •Anesthesia
- •Modality for guidance
- •Radiofrequency ablation
- •Microwave ablation
- •Cryoablation
- •Adjacent structures
- •Postprocedure follow-up
- •Complications
- •Treatment of metastatic disease
- •Surgical and RFA options
- •Medical therapies
- •Conclusion
- •References
- •23 Embolotherapy in the management of renal cell carcinoma
- •Introduction
- •Basic concepts
- •Embolization technique
- •Preoperative embolization
- •Radical nephrectomy
- •Partial nephrectomy
- •Postoperative embolization
- •Palliative embolization
- •Complications
- •Conclusion
- •References
- •Physics of ablation therapy
- •Radiofrequency ablation
- •Microwave ablation
- •Cryoablation
- •Irreversible electroporation
- •Performing ablation therapy
- •Patient selection
- •Procedure
- •Radiofrequency ablation
- •Microwave ablation
- •Cryoablation
- •Irreversible electroporation
- •Imaging follow-up
- •Radiofrequency ablation
- •Microwave ablation
- •Cryoablation
- •Irreversible electroporation
- •Comparison of thermal ablation techniques
- •Applications and outcomes for thoracic ablation
- •Palliation
- •Conclusion
- •References
- •Introduction
- •Indications for treatment
- •Preprocedural imaging
- •Contraindications to ablation treatment
- •RFA technique
- •RFA pain palliation outcomes
- •Cryoablation technique
- •Cryoablation pain palliation outcomes
- •Emerging technologies
- •Summary
- •References
- •26 Cementoplasty and musculoskeletal interventions
- •Introduction
- •Indications
- •Contraindications
- •Technique
- •Postprocedural care and follow-up
- •Current bone cement properties and future directions
- •Percutaneous sacroplasty, osteoplasty, and advance hybrid stabilization techniques
- •Summary
- •References
- •27 Prostate ablations
- •Introduction
- •Patient selection
- •Cancer detection and treatment guidance
- •Patient selection
- •Targeting strategies
- •Image guidance for prostate ablation
- •Ultrasound guidance
- •MR guidance
- •Computed tomography guidance
- •Positron emission tomography guidance
- •Prostate ablation techniques
- •High-intensity focused ultrasound
- •Cryoablation
- •Other techniques
- •Postprocedure evaluation
- •Complications and outcomes
- •Local control
- •Conclusion
- •Acknowledgments
- •References
- •Indications
- •Rationale
- •Technique
- •Catheter positioning
- •Contraindications
- •Results
- •Port/catheter placement
- •Chemotherapy
- •Description
- •Indications
- •Preoperative assessment
- •Catheter tip location
- •Update on vein thrombosis prophylaxis and treatment
- •Catheter-related infection
- •References
- •29 Palliative care and symptom management
- •Palliative care and communication with cancer patients
- •Communication with cancer patients
- •Prognostication
- •Medical symptom management
- •Pain
- •Non-opioid analgesics
- •Opioid analgesics
- •Adjuvant analgesics
- •Bone metastases
- •Nausea and vomiting
- •Constipation
- •Constitutional symptoms
- •Ascites
- •Psychiatric symptoms
- •Depression
- •Anxiety
- •Summary
- •References
- •Introduction
- •Celiac plexus neurolysis
- •Anatomy
- •Technique
- •Positioning and approach
- •Antecrural
- •Retrocrural
- •Outcomes
- •Complications
- •Superior hypogastric neurolysis
- •Anatomy
- •Technique
- •Positioning and approach
- •Outcomes
- •Complications
- •Ganglion impar neurolysis
- •Anatomy
- •Technique
- •Outcomes
- •Complications
- •References
- •Introduction
- •Management of ascites
- •Diuretics and sodium restriction
- •Large-volume paracentesis
- •Permanent indwelling catheters
- •Pigtail or Cope-type loop catheter
- •PleurX and Asept catheters
- •Peritoneal Port-A-Catheters
- •Thoracentesis
- •Chest drainage catheters
- •Pigtail catheters
- •Tunneled catheters
- •Summary of recommendations and guidelines
- •References
- •Index

newgenprepdf
Contributors
Riad SalemMD
Department of Radiology, Section of Interventional Oncology,
Northwestern University, Robert H.Lurie Comprehensive
Cancer Center, Chicago, IL,USA
Lynn JeanetteSavic
Russell H.Morgan Department of Radiology and Radiological
Science, Division of Cardiovascular and Interventional
Radiology, Johns Hopkins Hospital, Baltimore, MD,USA
Constantinos T.Sofocleous
Department of Radiology, Section of Interventional
Radiology, Memorial Sloan Kettering Cancer Center,
NewYork, NY,USA
Stephen B.SolomonMD
Interventional Radiology Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, NewYork, NY,USA
Michael C.Soulen MD FSIRFCIRSE
Department of Radiology, Abramson Cancer Center,
University of Pennsylvania, Philadelphia, PA,USA
Govindarajan SrimathveeravalliPhD
Interventional Radiology Service, Department of
Radiology, Memorial Sloan Kettering Cancer Center,
NewYork, NY,USA
Ursina TeitelbaumMD
University of Pennsylvania, Philadelphia, PA,USA
Ashraf ThabetMD
Department of Radiology, Massachusetts General Hospital,
Boston, MA,USA
Sean Tutton MDFSIR
Department of Radiology, Medical College of Wisconsin,
Milwaukee, WI,USA
Vlastimil Valek MD CScMBA
Department of Radiology, University Hospital Brno and
Medical Faculty, Masaryk University, Brno, Czech Republic
Aradhana M.VenkatesanMD
Radiology and Imaging Sciences and Center for
Interventional Oncology, NIH Clinical Center, Bethesda,
MD,USA
Bradford J.WoodMD
Department of Radiology, Center of Interventional Oncology,
NIH Clinical Center, Bethesda, MD,USA
Hooman YarmohammadiMD
Department of Radiology, Memorial Sloan Kettering Cancer
Center, NewYork, NY,USA
ix


Section I
Chapter
Principles of oncology
Interventional oncology:The fourth pillar of
cancercare
In the years since the rst edition of this book, interventional
oncology (IO) has continued to establish itself as an essential
pillar within the rmament of multidisciplinary oncologic care,
alongside medical, surgical, and radiation oncology. e perception of IO has evolved from ignorance or skepticism into
something that is taken for granted by knowledgeable oncologists, who now refer patients with the expectation that we will
counsel appropriate image-guided therapies to oer optimal
benet, and integrate that therapy into an oncologic care plan
with our sister disciplines. is gratifying status is a result of
years of eort to establish the credibility of our discipline. e
path is now open to any practitioner of minimally invasive,
image-guided therapy to build an IO practice.
starts with common services for cancer patients such as venous
and enteral access, biopsies, and palliative procedures. ese
basic services, although poorly remunerated and demanding little or no longitudinal care outside of the interventional
radiology (IR) suite, are the initial point of contact with cancer
patients and their referring oncologist. Viewed as a free IO consultation, every biopsy, chest port, or paracentesis provides an
opportunity to oer more sophisticated services to manage the
patient’s cancer, and to educate patients and fellow oncologists
about the valueofIO.
mon to all clinical practices– an oce with examination rooms,
staed by receptionists, secretaries, medical assistants, nurses,
nurse practitioners, physician assistants; an electronic medical
record; and billing and pre-certication services. e number
of support sta will equal or exceed the number of physicians.
Yet this investment is essential to a robust and protable practice. IO services are more remunerative than other IR services
over the long run and will evolve to dominate group income.
Downstream professional revenue per new IO consultation,
including imaging as well as therapeutic services, is extremely
high. Cancer has surpassed cardiovascular diseases and is now
the leading cause of death worldwide. Given the increasing
role of IO, growth in the eld is guaranteed for the foreseeable
future.
free-standing centers capturing global charges are an attractive
1
Michael C. Soulen and Jean-François H. Geschwind
Entry into an IO practice for an interventional radiologist
Establishing an IO practice requires an infrastructure com-
With hospital-based professional reimbursement declining,
alternative for many IO services. ese require substantial
investment to create and sta the facility, and volumes must be
maintained near capacity, but they oer the satisfaction of providing high-quality services outside of a hospital environment.
e grandest infrastructure will fail without an interventional oncologist who has the skill and the will to grow a practice. To be the fourth pillar of clinical oncology requires much
more than the technical skills learned in fellowship. To earn the
condence of referring physicians, interventional oncologists
need to speak the language of oncology, and be able to care for
cancer patients longitudinally. is requires an intimate knowledge of the science and practice of IO, expressed in language
common to other cancer specialists. It also requires education in the fundamentals of the other oncologic disciplines,
so that interventional oncologists convey understanding and
respect for what they have to oer, and can communicate all
options to their patients. Another requisite is familiarity with
the widely accepted treatment guidelines for various cancers
which, while oen not based on strong evidence, nonetheless
form the basis for most treatment plans. is new edition of
Interventional Oncology:Principles and Practice of Image-Guided
Cancer erapy incorporates the standard oncologic guidelines
for each cancer type to help prepare you for your role in this
excitingeld.
Tumor Boards are the gateway to an IO practice. Market
research has revealed that major barriers to referral for IO
services are the lack of familiarity among medical oncologists
about IO services and the people who oer them. Presence at
Tumor Board is critical to overcome these barriers. ere are
always patients for whom no good alternatives remain except
IO therapies. Establishing credibility as a member of the team
by oering care to these patients eventually leads to acceptance
of earlier integration of IO services.
While skill and will are essential, data are the coin of the
realm for oncologists. Unfortunately, image-guided therapies do not lend themselves well to trial designs familiar
to and accepted by the medical oncologists who write the
guidelines. Interventional oncologists have accepted these
limitations inherent in the eld and have evolved away from
single-institution, retrospective, underpowered reports that
have no inuence on clinical practice. Along-term challenge
Interventional Oncology, Second Edition, ed. Jean-François H.Geschwind and Michael C.Soulen. Published by Cambridge University Press.
© Cambridge University Press2016
1

Section I: Principles of oncology
for IO is to design and execute prospective, multicenter clinical
trials that oer compelling outcomes that will change therapeutic paradigms. On that front, although IO still has a long way
to go, tremendous progress has been made over the last decade.
e bar has been raised by interventional oncologists to the
point where procedures have been incorporated into accepted
clinical guidelines through data provided by care-changing
clinical trials. As a result, the credibility of IO has risen. One
can take the example of primary liver cancer (hepatocellular
carcinoma) where two therapies performed by interventional
oncologists, ablation and chemoembolization, are part of the
treatment guidelines worldwide. Not only are they included in
the guidelines, but the evidence to get these procedures to that
level was the highest possible, i.e., level 1a. at is a remarkable
achievement given that the eld of interventional oncology is
stillnew.
Since then, and as a result of having raised the bar so high,
many clinical trials have been conducted designed to answer
extremely important and relevant clinical questions. e new
norm consists of prospective multicenter phase II or III studies,
either single-arm or randomized. Growing acceptance by the
three other branches of oncology can only lead to improvement
in patient care. Aer all, this is what all interventional oncologists desiremost.
2

Section II
Chapter
Principles of image-guided therapies
Principles of radiofrequency and microwave tumor ablation
2
Anthony M. Esparaz, S. Nahum Goldberg, and MuneebAhmed
Keypoints
• Radiofrequency(RF)ablationand/ormicrowaveablation
areviablealternativesforthetreatmentofmanysolidfocal
malignancies,especiallyinthenon-surgicalcandidate.
• Benetsofimage-guided,minimallyinvasiveenergy
ablationincludelowmorbidityandmortality,lowcost,
inclusionofnon-surgicalpatients,andsame-daydischarge.
• ebasicprinciplesofRFandmicrowaveablationcanbe
dividedintothreemainelements,including:(1)biology
ofheating;(2)RFandmicrowavetechnology;and
(3)operatorexpertiseandtechnique.
• Successfultreatmentisobtainedwhenbalancingbetween
completetumordestructionandminimizingdamageto
surroundingnormalparenchymaandadjacentstructures.
• WidespreadadoptionofRFandmicrowaveablation
willrelyuponimprovingandincreasingtumorablation
volume.Adjuvanttherapiessuchaschemotherapeutics,
antiangiogenics,embolization,andradiationholdgreat
promiseinthiscapacity.
Introduction
Image-guided, minimally invasive tumor ablation aims to
eradicateorsubstantiallydestroyfocaltumorsbyinducingirreversiblecellularinjurythroughtheapplicationofthermaland
non-thermalenergyorchemicalinjection.1Ablativemodalities
canbedivided intoenergy-basedablationandchemicalablation.While chemical ablation uses agentssuchas ethanol or
aceticacidtoinducecoagulationnecrosisandtumorablation,
energy-basedablativetechniquesdestroyatumorviathermal
(heat or cold) or non-thermal techniques.1 Two examples of
energy-basedmodalities,RFablationandmicrowaveablation,
aretheprincipaltopicofthischapter.esetherapies,initially
RFablationandnow,toanever-increasingextent,microwave,
havegained widespread attentionin the medical community
and have become broadly accepted as methods for treating
focalmalignanciesinawiderangeoftumortypesandtissues.
ese include primary and secondary malignancies of the
liver,kidney,lung,andbone.
2–7
Giventhemultiplicityoftreatmenttypes,complexityofparadigmsinoncology,anddiverse
application of energy-based ablation techniques, a thorough
understandingofthe basic principles and recent advances in
RFandmicrowaveablationisanecessaryprerequisitefortheir
eectiveclinicaluse(Figure2.1).
e ultimate goal of minimally invasive, energy-based
tumorablationforfocalmalignanciesistocompletelyeradicate
allviablemalignantcellswithinthetargettumor.Based upon
tumorrecurrencepatternsandpathologicanalysesinlong-term
studiesinpatientswho have undergonesurgical resection or
ablation,there are oenviable persistent microscopictumor
fociinarimofapparentlynormal surrounding parenchymal
tissue beyond the visible tumor margin. erefore, tumor
ablationtherapies also attemptto include a 5–10-mm “ablative”marginofnormalsurroundingtissueinthetargetzone,
particularlyintheliverand lung.
8,9
erequiredthickness of
thismarginisvariablebasedupontumorandorgantype,asa
smallermarginmaybeneededforsometumorsinthekidney.
Additionally, given that completetumordestruction only
occurswhentheentiretargettumorisexposedtoappropriate
temperatures,asingleablationtreatmentislikelynotsucient
toentirelyencompassthetargetvolumeofalargertumor(usuallydenedasgreaterthan3–5cmindiameter).10epattern
oftissue heatinginthe targettumormustalsobeconsidered.
us, multiple overlapping ablations or simultaneous use of
multipleapplicatorsmayberequiredto successfullytreatthe
entiretumorandachieveanablativemargin.
11,12
Finally,whilecompletetreatmentofthetargettumorisof
primary importance, specicity and accuracy are also highly
preferred,withasecondarygoalofincurringaslittleinjuryas
possibletosurroundingnon-targetnormaltissue.isability
tominimizedamagetonormalorganparenchymaisoneofthe
signicantadvantagesofRFandmicrowaveablation,andcan
becriticalinpatientswhohavefocaltumorsinthesettingof
limitedfunctionalorganreserve.Examplesofrelevantclinical
situationsincludefocalhepatictumorsinpatientswithunderlyingcirrhosisandlimitedhepaticreserve,patientswithfamilialmultiplerenal cellcarcinomassuchas vonHippel–Lindau
syndromewhohavelimited renal function andrequiretreatmentof multiplerenal tumors, and those with primary lung
tumorswithextensiveunderlyingemphysemaandlimitedlung
function.
13,14
Manyofthesepatientsarenotsurgicalcandidates
duetolimitednativeorganfunctionalreserve,placingthemat
ahigherriskforpostoperativecomplicationsororganfailure.
Interventional Oncology, Second Edition, ed. Jean-François H. Geschwind and Michael C. Soulen. Published by Cambridge University Press.
©Cambridge University Press2016
3

Section II:Principles of image-guided therapies
Optimizing Tumor Ablation:
typesdieinafewminuteswhenheatedat50°C.17us,optimal
temperaturestoensureablationlikelyexceed 50°C. However,
tissuevaporizationoccursattemperatures>110°C.isinturn
Technique
Operator
limitsfurthercurrentdepositioninRF-basedsystems(ascomparedtomicrowavesystemsthatdonothavethislimitation).
Immediate cellular damage is principally due to protein
Technology
Adjuvants
Figure 2.1 Conceptualization of the key components necessary to achieve
optimal ablation. The three key components for achieving successful
radiofrequency (RF) ablation include technology (i.e., the RF generator and
electrodes selected); the biology of the tumor and background tissue; and
operator factors. Interfaces between technology and biology include adjuvant
therapies that modulate these two factors. Technique defines the interface
between technology and operator, whereas patient selection represents the
operator interacting with tumor biology.
Optimal
Ablation
Patient
Selection
Biology
coagulation of cytosolic and mitochondrial enzymes and
nucleic acid–histone protein complexes, which triggers cellulardeathoverthecourseofseveraldays.18“Coagulation” is
thestandardizedterminologyusedtodescribethegrosspathological appearance of treated tissue aer thermal damage.
Nonetheless,theultimatemanifestationsofcelldeathmaynot
meet strict histopathologic criteria of coagulative necrosis.19
ishasnotableimplicationsin clinicalpractice,aspercutaneousbiopsyandstandardhistopathologicinterpretation,particularlybystandardhematoxylinandeosinstaining,maynot
beareliablemeasureofadequatetumorablation.
19
eexacttemperatureatwhichcelldeathoccursismultifactorialandtissue-specic.Studieshaveshownthat,dependingonheatingtime,rateofheatincrease,andthetissuebeing
heated,maximumtemperaturesattheedgeofablationarevariable.Forexample,maximumtemperaturesatthe edge ofthe
ablationzone,knownasthe“criticaltemperature,”havebeen
Indeed,theabilitytominimizedamagetosurroundingnormal
tissueshasfueledtherapidacceptanceofRF andmicrowave
ablation.
showntorangefrom30°Cto77°Cfornormaltissuesandfrom
41°Cto64°Cfortumormodels(a23°Cdierence).20Likewise,
thetotalamountofheatadministeredforagiventime(thermal
dose) varies signicantlybetween dierent tissues. us, the
Biology of heating
Radiofrequency ablation
RF ablation produces irreversible cellular injury by focal
high-temperaturetissueheatinggeneratedaroundanRFelectrode.CurrentlyavailabledevicestraditionallyutilizedforRF
ablationfunctioninthe375–500-kHzelectromagneticenergy
range.1e mechanism of RF ablation is likened to a simple
electrical circuit. Electrical current fromthegeneratoroscillatesbetweenelectrodesthroughionchannelspresentinmost
biologicaltissues.etissueitselfservesastheresistiveelement
ofthecircuit.Focalheatisgeneratedintheimmediatearea.As
RFcurrenttravelstotheremotegroundingpadfromtheapplicatorand because tissues areimperfectelectricalconductors,
local tissue resistance to current ow causes frictional ionic
agitationandheat generation,knownastheJouleeect.e
second mechanism of tissue heatingreliesuponthermal tissueconduction.15Heatgeneratedaroundtheelectrodediuses
throughthetumorandresultsinadditionalhigh-temperature
heatingthatisseparatefromthedirectenergy–tissueinteractionsthatoccuraroundtheelectrode.
e endpoint of RF ablation is tissue heating adequate
to induce coagulation throughout the dened target area.
Relatively mild increases in tissue temperature above baseline (40°C) can be tolerated by normal cellular homeostatic
mechanisms, and low-temperature hyperthermia (42–45°C)
resultsinreversiblecellular injury,whichcanincrease cellularsusceptibilitytoadditionaltherapiessuchaschemotherapy
andradiation.16Irreversiblecellularinjury,ontheotherhand,
occurswhencellsareheatedto46°Cfor60minutes.Mostcell
thresholdtargettemperatureof50°Cshouldbeusedonlyasa
generalguideline.
Microwave ablation
eterm“microwave”describeselectromagneticenergyinthe
300-MHzto300-GHzrange,and becauseofthis,microwave
ablationfunctionswithinthespectrumof,and isasubsetof,
RF ablation.1 However, the mechanism of microwave tissue
heatingand destruction isdistinct from that ofRF ablation.
Microwaveheating is produced as a result of dielectric hysteresis,orrotatingdipoles.21Whenelectromagneticenergyis
appliedtotissue,someofitisusedtoforcemoleculeswithan
intrinsic dipole moment(i.e., water) to continuouslyrealign
with the applied eld. is rotation of molecules represents
anincreaseinkineticenergyandaresultantelevationinlocal
tissuetemperatures.erefore,tissueswitha higherpercentageofwater,suchasmostsolidorgans,aremoreconduciveto
microwaveheating. Conversely,less heatingoccurs in tissues
withlowerwatercontent,suchasfat.22Forpracticalandregulatoryreasons,microwaveablationdevicesaretypicallyoperatedateither915MHzor2.45GHz.
Several componentscomprisea basicmicrowaveablation
system:a generator,a power distribution system, and antennasthatmostoencontainacrucialcoolingsystemtoprotect
against antenna sha heating.21 e energy from the microwavegeneratorisdeliveredviaacoaxialtransmissionline to
aninterstitialantenna,whereitisthendeliveredintoavolume
oftarget.Mostantennasutilizeastraightneedle-like design,
although deployable loops have also been reported.23 ose
with smaller diameters may have diculty handling higher
4

Chapter2:Radiofrequency and microwave tumor ablation
powers,with resultantthermal damage aroundtheproximal
antennasha. erefore,coolingsystems, suchascirculation
ofchilledwaterorsaline,orcoolingjacketsarecrucialtoprotect against skin burns. Moreover, active cooling allows the
deliveryofhigherpowersforlongerperiodsoftime,resulting
inlargerablationzones.
Tissue factors aecting RF ablation
Anunderstandingoftheeectofthetumorandorganbiophysiologicenvironmentontissueheatingiscriticaltoperforming
successfultumorablations.Moststudiestodatehavefocused
on the eects of tissue characteristics on RF ablation. For
example,tissue-heating patterns vary based upon the tumor
andtissuecharacteristicsthatmayaectthermalconduction.
e foremost factor limiting thermal ablation of tumors
continues to be tissue blood ow, for which the eects are
twofold:
1. Large-vesselheat-sinkeect.Larger-diameterbloodvessels
withhigherowactasheatsinks,drawingawayeitherheat
(orcold)fromtheablativearea.Forexample,inastudyin
anin-vivoporcinemodel,Luetal.examinedtheeect of
hepatic vessel diameter on RF ablationoutcome.24 Using
computedtomography(CT)and histopathologicanalysis,
more complete thermal heating and a reduced heat-sink
eectwereidentiedwhenhepaticvesselswithintheheat-
ing zone were < 3 mm in diameter. In contrast, vessels
>3mmindiameterhadhigherpatencyrates,lessendothe-
lialinjury,andgreaterviabilityofsurroundinghepatocytes
aerRFablation.
2. Microvascularperfusion.Anothereectoftissuevascula-
tureisaresultofperfusion-mediatedtissuecooling(capil-
laryvascularow),whichalsofunctionsasaheatsink.By
drawingheatfromthe treatmentzone,thiseectreduces
the volume of tissue that receives the required minimal
thermal dose for coagulation. Several studies have used
pharmacologicalterationoftissueperfusiontoreducethese
eects.Goldbergetal.modulatedhepaticbloodowusing
intra-arterialvasopressinandhigh-dosehalothaneincon-
junctionwithRFablationinin-vivoporcineliver.25Arsenic
trioxide has recently received increasing attention as a
novelantineoplasticagentthathasbeenshowntopreferen-
tiallydecreasetumorbloodowandsignicantlyincrease
RF-inducedcoagulationin a renaltumormodel.26Recent
dependent on local electrical conductivity. To this end, the
eectoflocalelectricalconductivitycanoccurinseveralways:
1. Eect of diering tumor and surrounding organ electrical conductivity.Dierencesinelectricalconductivitybetweenthe
tumorand surrounding background organ can aect tissueheatingatthetumormargin.Severalstudieshavedemonstrated increases in tissue heating at the tumor–organ
interfacewhen the surroundingmedium is characterized
byreducedlowerelectricalconductivity.29Incertainclinicalsettings,suchastreatingfocaltumorsineitherlungor
bone, marked dierences in electrical conductivity may
resultinvariableheatingatthetumor–organinterface,and
indeed,limitheatinginthesurroundingorganandmake
anappropriateablativemargindiculttoobtain.
2. Altering electrical conductivity of the target zone. Altering
theelectricalenvironmentimmediatelyaroundtheRFelectrodewithionicagentscanincreaseelectricalconductivity
priortoorduringRFablation.eincreaseinconductivity
allowsgreaterenergy deposition and,therefore,increased
coagulationvolume.30Saline mayalso be of benet when
attempting to ablatecavitary tumors that might not otherwise contain a sucientcurrentpath.Ingeneral,small
volumesof highly concentratedsodium ions are injected
inandaroundtheablationsite tomaximizelocalheating
eects.31However,itshouldbenotedthatsalineinfusion
isnotalwaysapredictableprocess,asuidcanmigrateto
unintendedlocationsand causecomplicationsif notused
properly.Additionally,too muchsaline can increase conductivitytothepointthatlessheatingisachieved.
Anothercharacteristictoconsiderisatissue’sthermal conductivity. Initial clinicalstudiesusingRFablationforhepatocellularcarcinomainthesettingofunderlyingcirrhosisnotedan
“oven” eect (i.e., increased heating ecacy for tumors surroundedbycirrhoticliver or fat, suchasexophyticrenalcell
carcinomas),oralteredthermaltransmissionatthejunctionof
tumortissueandsurroundingtissue.10Verypoortumorthermal conductivity limitsheat transmission centrifugallyaway
fromtheelectrodewithmarkedheatinginthecentralportion
ofthetumor,withthepotentialforlimitedheatinginthetumor
periphery.Incontrast,increasedthermalconductivity(suchas
in cysticlesions or tumorssurrounded by ascites) results in
fastheattransmission (i.e.,heatdissipation),with potentially
incompleteandheterogeneoustumorheating.
studies have demonstrated modication of tumor vesseldensityusing antiangiogenicagents,suchassorafenib,
toincreaseRF coagulation. In one study,the administrationofsorafenibpriortoRFablationmarkedlydecreased
microvasculardensityandledtosignicantlylargerzones
ofRF-inducedcoagulationnecrosis.27Finally,pre-ablation
intra-arterial microembolization (using 100–500-μm particles),either alone or as part ofperformingtransarterial
chemoembolization(TACE),hasalsobeenusedtoincrease
thesizeoftheablationzone.
28
Inadditiontotissueperfusionproperties,local electrical conductivity is a tissue characteristic that specically inuences
energy deposition in RF-based systems, which are strongly
Tissue factors aecting microwave ablation
Relativepermittivity,eectiveconductivity,andbulkconduct-
ivityarethemostimportantpropertiesthatdeterminehowthe
biophysiologicenvironmentaectsmicrowaveenergypropa-
gationandtissueheating.Relativepermittivity,orthe“dielec-
tricconstant,”measureshowwellatissuewillacceptanelectric
eld compared to the relative permittivity of a vacuum.
isimpactsenergypropagationthroughatissue,withhigher
permittivities leading to shorter wavelengths. On the other
hand, eective conductivity refers to the rotationof dipoles
andmeasureshowwellaspecictissuewillabsorbmicrowave
energy. is is in contrast to electrical conductivity for RF
21,22
5

Section II:Principles of image-guided therapies
ablation,whichcharacterizesanalternatingowofelectrons.22
Describedearlier,tissuescomprisedofahigher percentageof
waterreadilyabsorbmicrowavesandthushavehigh eective
conductivities.A tissue’s bulk conductivity,whichreects the
amountofenergy loss inside a material,mustbeconsidered
formicrowave-inducedheating.SimilarlytoRF ablation,the
rateof blood perfusion inatissueaects microwaveablation
zonesize as heat isdrawnawayfromthe ablation zone periphery.Yet,somehavereported thatthis perfusion-mediated
coolingislessthanthatobservedforRFgivenhigherstarting
temperatures.
21,32,33
powersincreaseablationzonesize,butexcessivepowerinthe
antennashacanleadtounintendedinjuriestoothertissues,
suchastheskin.34Addingacoolingjacketaroundtheantenna
canreducecableheatingandeliminateskinburnswhileeectivelyincreasingtheamountofpowerthatcansafelybedeliveredtothetumor.
36
RFablation,ontheotherhand, hassteadilygainedbroad
acceptanceasatreatmentmodalityfor small (< 3 cm) hepatocellular carcinomas and colorectal metastases to the liver,
althoughmanyofthe currentlyutilized devicesrequiremultipleinterstitialelectrodeplacements,whichinturnincreases
the invasiveness of the procedure. While RF ablation is also
Radiofrequency ablation vs. microwave ablation–
benets and trade-os
Whileeachenergy-basedablationtechniqueisdistinct,thegoal
ofeachistoelevatetissuetemperaturesenoughtocreatezones
ofirreversiblecellulardamage.RFenergyisrelativelyinexpensiveandeasy to generate,butis limited bytheneedforelectricalcurrentow.Forthisreason,RFsuersinareasofhigh
bloodoworhightissueimpedance(e.g.,lung),andrequires
electricalswitchingforeectivemultiple-applicatoruse.
Importantly, the chief distinction between RF andmicrowaveablationliesinthearea oftissueheatingproduced.22In
RFablation,tissue heatingislimitedto areasofhighcurrent
density,whileavolumearoundtheapplicatorantennaisheated
in microwave ablation. erefore, an electrically conductive
pathisnecessaryforRFheating,butnotformicrowaves,which
can propagate through tissues with little or no conductivity.
Essentially, low-conductivitytissues will allow better microwavepropagation,whilehinderingRFcurrent.
Microwaveheating is fast and ecientand,thus,appears
betterequippedtoovercomeheatsinksandtreatlargetumor
volumes.Microwavesarealsorelativelytissue-insensitiveand
oerimproved multiple-applicatorsupport,butcanbe more
diculttodistributethanotherenergysources.
As such, microwave energy has demonstrated several
advantages for tissue ablation.
34,35
Microwaves readily penetratethroughbiologicalmaterials, includingthose with low
electricalconductivitysuchaslungandbone,anddehydrated
or charred tissue. Consequently, microwave power can be
continuallyappliedtoproducevery hightemperatures(over
150°C),whichimprovesablationecacybyincreasingthermal
conductionintothesurroundingtissue.32Microwavesalsoheat
tissuemoreecientlythanRFenergyintissue;microwavesdo
notrequiregroundpads;andmultipleantennascanbeoperated simultaneously.33 In fact, due to the improved passive
heatingof the tumor margin byincreased thermal gradients
frommicrowavesandsucheectivepropagationofmicrowave
energythroughnormallung,microwaveablationmaybeideallyttingforthetreatmentofpulmonarytumors.
22
Ontheotherhand,microwaveenergyisinherentlymore
diculttodistributethanRFenergy.Microwavesmustbecarriedinwaveguides,suchascoaxialcable,whichare typically
morecumbersome than thesmall wires used to feedenergy
to RF electrodes and prone to heating when carrying large
amounts of power. It is well known that higher microwave
gainingpopularityforthetreatmentofpulmonarytumors,it
has met limited success.is is largelydueto the decreased
ability of RF to penetrate through aerated, low-conductivity
lungtissueandlimitationsinthermalconductionrequiredto
createanadequateablativemargin.Infact, low conductivity
andpoorthermalconductionarethesamelimitingfactorsfor
RFablationecacyinbone.Inthekidneys,RFhasbeenused
to eectively ablate small renal cell carcinomas.22 However,
high perfusion ratesnearthe calyces andrenal hila produce
heatsinksthat areproblematicforanyenergy-basedthermal
ablationmodalities.
Energy-deposited technology
Development of energy-based, thermal ablation technology
has,notsurprisingly, focused on the abilitytosafelyincrease
andimproveenergy depositioninto target tissue and to reliably achieve larger ablation zones. Energy algorithms, electrodesandapplicators,andgeneratorscanbealteredtodeliver
acomplexalgorithmofdieringmagnitudesandspectrumof
RFandmicrowaveenergy.Overall,thesestrategieshavebeen
balanced with the need for smaller-caliber devices, for their
continueduseinaminimallyinvasivemanner.
Multiapplicatorarrays
e easiest way to increase the volume of coagulation is to
lengthentheexposureoftheRFapplicatortip.However,this
resultsina cylindricallesionshape thatdoesnotcorrespond
wellwiththesphericalgeometryofmosttumors.Onemethod
tocreatemoresphericalablationistomanuallyinsertasingle
applicatormultipletimesinasingleprocedure.
thisistime-consumingandcomplicated,makingitimpractical
forroutineuseinaclinicalsetting.
us, using multiple conventional monopolar RF applicatorssimultaneouslyin a pre-setcongurationcanincrease
ablationsize withoutprolongingtreatment time.
no greater than 1.5 cm between individual applicators can
produce uniform and reproducible tissue coagulation, with
simultaneousapplicationofRFenergyproducingmorenecrosisthan sequential application.Infact, this arrangementcan
increasecoagulationvolumebyover800%comparedtoasingleelectrode.
39
In similar fashion, multiple microwave antennas can be
used simultaneously to increase ablationsize and utilize thermal synergy when placed inclose proximity to one another.21
37–39
However,
37,39
Spacing
6

Chapter2:Radiofrequency and microwave tumor ablation
Alternatively,theantennasmaybewidelyspacedtoablatemore
thanonetumorconcurrently.UnlikeRFablation,multiapplicator microwave ablation can be poweredcontinuously without
switching between electrodes during activation. Additionally,
antennascanbepositionedandphasedconstructivelytoexploit
overlapoftheelectromagneticeld,whichallowsmoreecient
heating and generation of higher temperatures than a single
antenna.isfeatureisuniquetomicrowaveablation.Heating
increasesproportionallytothesquareofthenumberofantennas.
Moreover,thisincreaseinheatingissupplementaltothethermal
synergyseenwithothermultiapplicatorablationtechnologies.
Multitine applicators
Workingtoovercomethe technicalchallengesof multiprobe
application,whichrequiresmultiplepuncturesites,multitined
expandableRFelectrodeshavebeendeveloped.esesystems
involvethedeploymentofavaryingnumberofmultiplethin,
curved tines in the shape of an umbrella or more complex
geometriesfromacentralcannula.
uteenergyspatiallytoimproveheatingeciencyandincrease
total electrode surface area to ultimately create larger zones
ofablationinashorterperiodoftime.issurmountsearlier
diculties by allowingeasy placement of multiple probes to
createlarge,reproduciblevolumesofnecrosis,suchas up to
3.5cmindiameterinin-vivoporcineliveroreven>5cmusing
commerciallyavailableexpandableelectrodeswithoptimized
stepped-extensionandpowerinputalgorithms.
multitinedelectrodesaremoreinvasiveandmayincreasecomplication rates, especially in percutaneous settings, although
relevantcomparisonsbetweendevicesarelacking.
One type of multitined electrode utilizes three single
17-gauge electrodes, spaced 5 mm apart in a triangular congurationanddriveninparallelbythesamegeneratorsource
toeectivelybehaveasasingle,largerelectrodebutwithalimitedpuncturearea.Itcancreatezonesofablationover3cmin
diameterinnormalliverin12minuteswitha200-Wgenerator.44
Othermultitinedelectrodedesignsdeployseveralsmallerelectrodesfromasingleneedlesha.Twosuchdesignsareclinically
availabletodaythatcreateeitherstar-shapedorumbrella-shaped
arrays.Star-shapedelectrodes are deployable froma 14-gauge
(2.1mmdiameter)needleusingarraysoffour,nine,or12tines.
Umbrella-shaped electrodes, on the other hand, contain ten
tinesandaredeployedfroma13-gaugeneedle.esetinesare
electrically connected and operated in parallel, which means
that current owing through each tine can vary depending
uponlocaltissueproperties. Deployableelectrodesarecapable
40,41
eirgoalistodistrib-
40–42
Ingeneral,
43
with the conventional monopolar system.
tems, applied RF current oscillates between an active electrodetoa second interstitial groundingelectrode in place of
a grounding pad, theoretically utilizing twice as much heat
for ablation. Current ow is theoretically restricted primarily to the area between the electrodes and protectsthis area
from perfusion-mediated cooling, resulting in faster, more
focalheatingbetweenthe electrodes. is also eliminatesthe
needforsurfacegroundingpadsandtheriskofgroundingpad
burns.Bipolaroperationmayrequiremorepreciseplacement
oftheelectrodestocreateaconuentzoneofnecrosisandcan
belimitedbylocalchangesinconductivityresultingfromthe
ablation.48 For this reason, bipolar systems oen use saline
infusiontoincreaseenergydeliverybetweentheelectrodes.
However,theheatgeneratedaroundbothelectrodescreates
ellipticallesions,andwhilethisresultsinanoverallincreasein
coagulationvolume,theshapeofnecrosisisgenerallyunsuitable for tumorsthat are usually spherical, making thegains
in coagulation less clinically signicant. Some experimental
applicatorshaveutilizedacombinationofcryoablationandRF
inanattempttocreatemoresphericallesionswhilealsoutilizingtheproposedbenetsofabipolarsystem.
Internally cooled electrodes
OneofthelimitationstogreaterRFenergydepositionhasbeen
overheatingsurroundingtheactiveelectrode,leadingtotissue
charring, rising impedance, and RF circuit interruption. To
addressthis,internallycooledelectrodeshavebeendeveloped
thatarecapableofgreatercoagulationcomparedwithconventional monopolar RF electrodes.
cooledelectrodesdierfromperfusionelectrodes in thatthe
coolingagent(saline,water,orgas)doesnotcomeintodirect
contactwithpatienttissues.
Internally cooled electrodes contain two hollow lumens
thatpermitcontinuousinternalcoolingofthetipwithachilled
perfusate,andtheremovalofwarmedeuentto acollection
unitoutsideofthebody.isreducesheatingdirectlyaround
theelectrode,tissuecharring,andrisingimpedance,allowing
greaterRFenergydepositionandresultantbroaderdepthoftissueheatingfromthermalconduction.Withthistechnique,RF
energydepositedintotissueandresultantcoagulationnecrosisweresignicantlygreater(P < 0.001) than those achieved
withoutelectrodecooling.
torshaveused alternativecoolingagents(forexample,argon
ornitrogengas)toachieveevengreatercooling,andtherefore
largerzonesofablation,aroundtheRFelectrodetip.
37,40,44,50,51
1
50,51
Furthermore,severalinvestiga-
46,47
In these sys-
49
Notably, internally
49
ofcreatingzonesofablationapproximately5–7cmindiameter
in30–45minutes,althoughcareshouldbetakenwhenevaluatingdeviceperformance,sincedeployabledesignshavealsobeen
associatedwithirregularheatingpatterns.
42
Multitined applicators are currently in development for
microwaveablationplatforms.
45
Bipolararrays
Severalgroupshaveworkedwithbipolararraystoincreasethe
volume of coagulation created by RF application compared
Perfused electrodes
Incontrasttointernallycooledelectrodes,perfusionelectrodes
havesmallaperturesattheactivetip,allowinguids(i.e.,normalorhypertonicsaline)tobeinfusedorinjecteddirectlyinto
thetissuebefore,during,oraertheablationprocedure.is
mayimproveheatdiusionandelectricalandthermalconduction of the tissue.
this technique to improve the quality of ablation produced
bytheir applicator.
41,52,53
At least one system clinically utilizes
41,53
Sodium chloride(NaCl)will alterthe
7

Section II:Principles of image-guided therapies
tissuecharacteristicsinamannermorefavorableforablation
through multiple factors. First, NaCl increases the electrical
conductivity.Also,NaClpotentiallyimprovesthethermalconductionif theowrateishigh byaidingthediusionofheat
fromthecentralelectrode.53ereisalsoareductioninchar-
whichtimethesystemwouldtypicallybeapplyingnoenergy
torecuperate.Oneproposedtheoryisthat,becauseofelectricalinterferencebetweenelectrodes,thesimultaneousmethod
leadstoless heatingatthe centerthanrapidswitching,when
onlyasingleelectrodeisactiveatasinglepoint.
57
ringaswellthe“ushing”ofbubblesfromtheelectrodetract,
whichformduringRFablationandareknowntolimitelectricalconductance.Lastly,hypertonicNaClsolutionshaveamild
toxictumoricidalqualitywheninjectedalone.
53
Cooling in microwave ablation
Coolingsystemsthatsimultaneouslyincreasethepowerhandling of smaller-diameter antennas can reduce unwanted
skinburnsandtissuedamagebymicrowaveantennasathigh
powers.21 e most common cooling method is circulation
of chilled wateror saline. is strategy has enabled delivery
of higher powers for extended periods of time, with resultinglargerablationzones. One system (Certus 140, NeuWave
Medical,Madison,WI)usestherapiddecompressionofcarbondioxidegas,causingtheJoule–ompsonphenomenonat
theprobetipwithgasventingupthesha.High-powergenerators(140 W)andsmallsha diameterscanbe usedwiththis
system.
ClusterRF
Baseduponsuccessininducinggreatervolumesofnecrosisby
usingboth multiprobearraysandcooling,one standardsystemnowinvolvesthree2-cmtipinternallycooledapplicators
spaced0.5cmapart,producingreproducibleablationgreater
than3 cm in perfused liver.44is is one of themorepopularablationdevicescurrentlyusedintheclinicalsetting,with
muchreportedliterature.
8,54,55
Operator and technique
erearedierentapproachestoablationtreatments,includingwhoperformsablation,howitisperformed,andtheimagingguidancedevices used, be it ultrasound (with or without
contrast,whereavailable),computedtomography,and/ormagneticresonance.Allofthesewillhavesubstantialimpactonthe
ultimateresults.
Ablativemargin
Toachievecompletetumordestruction,theablationofappropriatetissuemarginsbeyondthebordersofthetargettumoris
essential.Formanyprocesses,particularlyintheliver,lung,and
kidney,mostinvestigatorssettheablativemarginsat5–10mm.
However, dataarecurrentlylackingtosupportdenitiverecommendationsforidealablativemarginsize.
Targettumors undergoing thermal ablation can be conceptuallydividedintothreezones:(1)acentralablationarea
which undergoes heat-induced coagulation necrosis; (2) a
peripheral rim which undergoes reversible changes from
sublethal hyperthermia; and (3) surroundingtumor or normaltissuethatis unaected by focal ablation, although still
exposed to concurrentand combinationtherapies.e area
of maximum synergy between ablation and adjuvanttherapies is the peripheral rim immediately surrounding the
high-temperatureablationzone.
eextentofinducedtumorcoagulationisideallyreported
58
in three dimensions, particularly including the short-axis
Pulsed RF application
Pulsingofenergy isanotherstrategy thathasbeenusedwith
RFtoincreasethemeanintensityofenergydeposition.When
pulsingisused,periodsofhigh-energydepositionarerapidly
alternatedwithperiodsoflow-energy deposition. Ifaproper
balancebetweenhigh-andlow-energydepositionisachieved,
preferentialtissuecoolingoccursadjacenttotheelectrodeduringperiodsofminimalenergydepositionwithoutsignicantly
decreasing heating deeper in the tissue. us, even greater
energycanbeappliedduring periodsof high-energy deposition, thereby enabling deeper heat penetration and greater
tissuecoagulation.56 Synergy between acombinationofboth
internalcoolingandpulsinghasresultedingreatercoagulation
necrosis and tumor destruction than either method alone.56
Pulsed-energytechniqueshavealsobeensuccessfullyusedfor
microwaveandlaser-basedsystems.
diameter.Importantly,microwaveablationcancauseimmediatetissuecontractionduetocollagenandproteinremodeling,
signicantwaterevaporation,anddehydrationwithintheablation zone.1us,ablationzonemeasurementsbyimagingor
gross inspection could underestimate the pre-ablation tissue
dimensions.
Choice of applicator
Animportantdecisionfortheoperatorinvolvesthechoiceof
applicator. Proper geometric coverage that involvescomplete
tumordestructionwhileminimizingnormaltissueispartially
dependent upon choice of single or multiple applicators.
Choiceofmultitineapplicatorinvolveswhen to use a cluster
electrodeversusagivenmultitinedapplicator.us,thereare
alsomanyvariationsintechnique described (orpracticed)as
tohowtoadequately,buteciently,coagulateatumor.
40,55
Switching RF applicatorenergy
Several RF generator systems that enable switching among
three electrically independent applicators have been created
that generate signicantly larger ablation than simultaneous
use.57 is relies upon switching energy to applicators duringtheimpedancespikesoftheremainingapplicators,during
Overlapping techniques
It is not uncommon that tumor burden exceeds the size of
ablationthatcan be reproduciblycreatedbyasingleablative
session,and,forthisreason,multipletreatmentsareoennecessary duringanRF ablationsessionforadequatetreatment.
is requires readjustment of the applicators into untreated
8
Соседние файлы в папке Библиотека им академика М.И. Перельмана
